Plain-English translation of NCT06781359 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that collects information from the medical records of patients who have been diagnosed with plasmablastic lymphoma, a rare type of blood cancer. Researchers will review how patients were diagnosed, staged, and treated, and what happened to them over time. The goal is to understand this disease better and improve how doctors recognize and care for patients with it.
Plasmablastic lymphoma is a rare cancer, and doctors don't have a lot of information about how to best diagnose and treat it. By studying real patients' experiences across many hospitals worldwide, researchers hope to create better guidelines for diagnosis and develop more effective treatment strategies.
You likely qualify if…
You likely don't qualify if…
If you qualify, you won't need to visit a clinic or take new medications. Instead, researchers will review your existing medical records and the tissue samples that were already collected when you were diagnosed. Your pathology samples will also be reviewed by expert pathologists to ensure the diagnosis was accurate and to standardize how this disease is identified. This is a one-time data collection process with no ongoing visits required.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Italy